Front page

Demographic shifts and the rising cost of care in Asia have boosted interest in the market, according to the SWF’s head of life sciences for direct investments in America.

Private equity investors are set to benefit from a re-pricing of unprofitable businesses in an era of high interest rates, according to the pension manager’s global head of PE.

The European giant says capital from private banks, family offices and aggregators could one day account for between 20% and 30% of its AUM.

While private companies generally performed well last year, the listed firm's top economic forecaster Nicholas Brooks says conditions will be choppier.

The European giant aims to increase the share of private wealth capital in its closed-ended products, which stands at under 10%.

US and European bases of operation will 'give us runway to continue doing what we’ve been doing', says PE chief Jim Pittman, including 'growing our book of directs'.

Speaking at the HKVCA’s annual forum, Colin Sau, managing partner of TR Capital, said the firm is increasing its focus on China in 2023 after a slowdown in recent years.

Dyal Capital Partners V is by far the biggest GP stakes vehicle ever raised. It is 43% larger than the 2019-vintage Fund IV, which set the previous record.

The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.

Even amid a tougher fundraising environment, climate funds are 'still very, very topical', says head of sustainable investing for private markets Ken Pontarelli.